Lexicon Pharmaceuticals | LXRX - 流动负债





流动负债 更改 日
Abbott USD 18.38B 1.88B 2026-03
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Akebia Therapeutics USD 173.88M 10.95M 2026-03
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Coherus Biosciences USD 140.39M 231.91M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Illumina USD 1.58B 12M 2026-06
Insmed USD 361.01M 107.87M 2026-03
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
J&J USD 54.9B 2.82B 2026-06
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
MannKind USD 134.56M 36.47M 2026-03
Merck USD 26.94B 1.38B 2026-03
Moderna USD 2.53B 139M 2026-06
Novartis USD 31.75B 374M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12